2m 2m 2m 2m 2m 2m 2m
Johnson&Johnson (JNJ)
NYSE
$235.45+$4.16 (+1.80%)
Price as of Jun 23, 2026 11:43 AM EDT- $556.8BMarket Cap
- 56.67%1-Year Change
- Drug Manufacturers - GeneralIndustry
Johnson&Johnson (JNJ)
$235.45+$4.16 (+1.80%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD GROUP INC | 9.98% | 240.3M | +3.7M (+1.55%) | Dec 31, 2025 |
BLACKROCK, INC. | 8.86% | 213.4M | +4.6M (+2.16%) | Mar 31, 2026 |
BLACKROCK FUNDING, INC. /DE | 8.36% | 201.3M | +1.4M (+0.68%) | Dec 31, 2024 |
BLACKROCK INC. | 8.23% | 198.2M | +8.5M (+4.27%) | Jun 30, 2024 |
N/A | 6.51% | 156.6M | +156.6M (+100.00%) | Mar 31, 2026 |
STATE STREET CORP | 5.54% | 133.5M | -393,555 (-0.29%) | Mar 31, 2026 |
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A. | 3.11% | 74.8M | +30,133 (+0.04%) | Dec 31, 2016 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 6.77% | 162.9M | +1.4M (+0.87%) | Mar 31, 2026 |
iSHARES TRUST | 2.20% | 52.9M | -1.2M (-2.19%) | Mar 31, 2026 |
FIDELITY CONCORD STREET TRUST | 1.62% | 39.1M | +510,094 (+1.31%) | Feb 28, 2026 |
DFA INVESTMENT DIMENSIONS GROUP INC | 1.26% | 30.4M | 0 (0.00%) | Jan 31, 2026 |
SPDR S&P 500 ETF TRUST | 1.17% | 28.1M | -1.3M (-4.54%) | Mar 31, 2026 |
VANGUARD FIXED INCOME SECURITIES FUNDS | 0.93% | 22.3M | 0 (0.00%) | Jan 31, 2026 |
VANGUARD SPECIALIZED FUNDS | 0.92% | 22.1M | -406,657 (-1.84%) | Jan 31, 2026 |
Current Ownership Distribution
- Institutions31.3B (81.04%)
- Mutual Funds7.1B (18.47%)
- Insiders187.3M (0.48%)
- Other0 (0.00%)
Insider Transactions
- 0.48% (187.3M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 9Number of InsiderSelling (last 12 months)
- $156.2MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Wengel Kathryn E EVP, Chief TO and Risk Officer | Exempt | Jun 11, 2026 | $0.00 | 10,000 | $0.00 | 32,965 |
Wengel Kathryn E EVP, Chief TO and Risk Officer | Exempt | Jun 11, 2026 | $1.2M | 10,000 | $115.67 | 124,288 |
Wengel Kathryn E EVP, Chief TO and Risk Officer | Sell | Jun 11, 2026 | $2.4M | 10,000 | $241.15 | 114,288 |
Pinto Daniel E | Award | Jun 09, 2026 | $31,249.96 | 134 | $232.79 | 2,321 |
Pinto Daniel E | Award | Mar 10, 2026 | $31,250.10 | 129 | $242.14 | 462 |
Woods Eugene A. | Award | Mar 10, 2026 | $37,499.98 | 155 | $242.14 | 5,240 |
Decker Robert J VP Corporate Controller | Exempt | Feb 27, 2026 | $0.00 | 4,075 | $0.00 | 0 |
Decker Robert J VP Corporate Controller | Exempt | Feb 27, 2026 | $471,355.25 | 4,075 | $115.67 | 27,757 |
Decker Robert J VP Corporate Controller | Sell | Feb 27, 2026 | $1.0M | 4,075 | $247.87 | 23,682 |
Schmid Timothy EVP, WW Chair, MedTech | Sell | Feb 20, 2026 | $324,762.52 | 1,322 | $245.66 | 25,447 |
Schmid Timothy EVP, WW Chair, MedTech | Exempt | Feb 18, 2026 | $0.00 | 13,625 | $0.00 | 0 |
Schmid Timothy EVP, WW Chair, MedTech | Exempt | Feb 18, 2026 | $0.00 | 8,998 | $0.00 | 0 |
Schmid Timothy EVP, WW Chair, MedTech | Exempt | Feb 18, 2026 | $1.6M | 13,625 | $115.67 | 40,394 |
Schmid Timothy EVP, WW Chair, MedTech | Sell | Feb 18, 2026 | $3.3M | 13,625 | $244.20 | 26,769 |
Schmid Timothy EVP, WW Chair, MedTech | Exempt | Feb 18, 2026 | $1.2M | 8,998 | $129.51 | 35,767 |
Schmid Timothy EVP, WW Chair, MedTech | Sell | Feb 18, 2026 | $2.2M | 8,998 | $244.53 | 26,769 |
REED JOHN C EVP, Innovative Medicine, R&D | Exempt | Feb 17, 2026 | $0.00 | 21,721 | $0.00 | 21,721 |
Swanson James D. EVP, CIO | Exempt | Feb 17, 2026 | $0.00 | 20,521 | $0.00 | 0 |
REED JOHN C EVP, Innovative Medicine, R&D | Exempt | Feb 17, 2026 | $0.00 | 29,927 | $0.00 | 59,854 |
Wolk Joseph J Exec VP, CFO | Exempt | Feb 17, 2026 | $2.2M | 19,241 | $115.67 | 58,202 |
REED JOHN C EVP, Innovative Medicine, R&D | Exempt | Feb 17, 2026 | $3.4M | 21,721 | $157.92 | 34,662 |
Swanson James D. EVP, CIO | Exempt | Feb 17, 2026 | $3.4M | 20,521 | $164.62 | 46,219 |
REED JOHN C EVP, Innovative Medicine, R&D | Sell | Feb 17, 2026 | $5.3M | 21,721 | $243.00 | 12,941 |
Broadhurst Vanessa EVP, Global Corp Affairs | Sell | Feb 17, 2026 | $1.5M | 6,197 | $243.39 | 23,003 |
REED JOHN C EVP, Innovative Medicine, R&D | Exempt | Feb 17, 2026 | $4.7M | 29,927 | $156.15 | 42,868 |
Swanson James D. EVP, CIO | Sell | Feb 17, 2026 | $5.0M | 20,521 | $242.70 | 25,698 |
REED JOHN C EVP, Innovative Medicine, R&D | Sell | Feb 17, 2026 | $7.3M | 29,927 | $243.00 | 12,941 |
Wolk Joseph J Exec VP, CFO | Sell | Feb 17, 2026 | $4.7M | 19,241 | $242.99 | 38,961 |
REED JOHN C EVP, Innovative Medicine, R&D | Sell | Feb 17, 2026 | $554,769.00 | 2,283 | $243.00 | 10,658 |
Wolk Joseph J Exec VP, CFO | Exempt | Feb 17, 2026 | $1.6M | 12,066 | $129.51 | 51,027 |